These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7029888)

  • 1. [B-lymphocyte immunology. Present status of knowledge].
    Májský A
    Vnitr Lek; 1981 Jul; 27(7):699-709. PubMed ID: 7029888
    [No Abstract]   [Full Text] [Related]  

  • 2. [HLA-DR and kidney transplant].
    Andreu J; Esteller E
    Med Clin (Barc); 1983 Mar; 80(7):327-33. PubMed ID: 6222226
    [No Abstract]   [Full Text] [Related]  

  • 3. MLC and HLA-DR typing: their relationship and relevance for transplantation.
    Cullen PR; Ting A; Morris PJ
    Transplant Proc; 1979 Mar; 11(1):756-9. PubMed ID: 156433
    [No Abstract]   [Full Text] [Related]  

  • 4. [When and why is it necessary to determine the HLA groups of a patient?].
    Kok-Van Alphen CC
    J Fr Ophtalmol; 1983; 6(2):203-11. PubMed ID: 6345647
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple specificities of B lymphocyte-reactive antibodies and their significance in renal allograft survival.
    Rhodes CL; Goldman MH; Mendez-Picon G; Lee HM; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1425-6. PubMed ID: 6390841
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA-DR antigens on CLL lymphocytes.
    Johnstone AP
    Br J Haematol; 1982 Feb; 50(2):378-9. PubMed ID: 6977375
    [No Abstract]   [Full Text] [Related]  

  • 7. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
    Drénou B; Blancheteau V; Burgess DH; Fauchet R; Charron DJ; Mooney NA
    J Immunol; 1999 Oct; 163(8):4115-24. PubMed ID: 10510346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of major histocompatibility antigens on human articular chondrocytes.
    Lance EM; Kimura LH; Manibog CN
    Clin Orthop Relat Res; 1993 Jun; (291):266-82. PubMed ID: 7684959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
    Wilson KM; Labeta MO; Pawelec G; Fernandez N
    Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
    Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
    J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
    Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
    Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B8 and erythema nodosum.
    Guyatt GH; Bensen WG; Stolmon LP; Fagnilli L; Singal DP
    Can Med Assoc J; 1982 Nov; 127(10):1005-6. PubMed ID: 6958347
    [No Abstract]   [Full Text] [Related]  

  • 15. [Histocompatibility patterns in multiple sclerosis. Findings of an epidemiological study (author's transl)].
    Poser S; Ritter G; Bauer HJ; Kuwert EK; Höher PG; Grosse-Wilde H; Hierholzer E
    Nervenarzt; 1981 Jun; 52(6):326-8. PubMed ID: 6973699
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenetic aspects of the relationship between HLA-DR and the MB and MT system.
    Duquesnoy RJ
    Transplant Proc; 1981 Dec; 13(4):1804-7. PubMed ID: 6977217
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
    Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
    J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable expression of major histocompatibility antigens: role in transplantation immunology.
    Koene RA; de Waal RM; Bogman MJ
    Kidney Int; 1986 Jul; 30(1):1-8. PubMed ID: 2427768
    [No Abstract]   [Full Text] [Related]  

  • 20. Presence of human B-lymphocyte antigens on adult T-cell leukemia cells.
    Hattori T; Uchiyama T; Takatsuki K; Uchino H
    Clin Immunol Immunopathol; 1980 Oct; 17(2):287-95. PubMed ID: 6967791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.